Found 3 results
Filters: Author is R.R. Réa  [Clear All Filters]
H. R. Frigeri, Santos, I. C. R., Réa, R. R., Almeida, A. C. R., Fadel-Picheth, C. M. T., Pedrosa, F. O., Souza, E. M., Rego, F. G. M., and Picheth, G., Low prevalence of glucokinase gene mutations in gestational diabetic patients with good glycemic control, vol. 11, pp. 1433-1441, 2012.
American Diabetes Association (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care 33 (Suppl 1): S62-S69. PMid:20042775 PMCid:2797383   American Diabetes Association (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care 34 (Suppl 1): S62-S69. PMid:21193628 PMCid:3006051   Arden C, Harbottle A, Baltrusch S, Tiedge M, et al. (2004). Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation. Diabetes 53: 2346-2352. PMid:15331544   Ben-Haroush A, Yogev Y and Hod M (2004). Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 21: 103-113. PMid:14984444   de la Iglesia N, Veiga-da-Cunha M, Van Schaftingen E, Guinovart JJ, et al. (1999). Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett. 456: 332-338.   Ellard S, Beards F, Allen LI, Shepherd M, et al. (2000). A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia 43: 250-253. PMid:10753050   Gloyn AL (2003). Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum. Mutat. 22: 353-362. PMid:14517946   Greeley SA, Tucker SE, Worrell HI, Skowron KB, et al. (2010). Update in neonatal diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 17: 13-19. PMid:19952737   Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. (2006). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr. Opin. Cardiol. 21: 1-6. PMid:16355022   Hayashi K (1991). PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl. 1: 34-38. PMid:1842918   Hollingsworth DR and Grundy SM (1982). Pregnancy-associated hypertriglyceridemia in normal and diabetic women. Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes 31: 1092-1097. PMid:6757021   Iynedjian PB (2009). Molecular physiology of mammalian glucokinase. Cell Mol. Life Sci. 66: 27-42. PMid:18726182 PMCid:2780631   Jetton TL, Liang Y, Pettepher CC, Zimmerman EC, et al. (1994). Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269: 3641-3654. PMid:8106409   Knopp RH, Chapman M, Bergelin R, Wahl PW, et al. (1980). Relationships of lipoprotein lipids to mild fasting hyperglycemia and diabetes in pregnancy. Diabetes Care 3: 416-420. PMid:7389557   Kousta E, Ellard S, Allen LI, Saker PJ, et al. (2001). Glucokinase mutations in a phenotypically selected multiethnic group of women with a history of gestational diabetes. Diabet. Med. 18: 683-684. PMid:11553210   Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444. PMid:1681511 PMCid:328920   Liang Z, Dong M, Cheng Q and Chen D (2010). Gestational diabetes mellitus screening based on the gene chip technique. Diabetes Res. Clin. Pract. 89: 167-173. PMid:20554072   Magnuson MA and Shelton KD (1989). An alternate promoter in the glucokinase gene is active in the pancreatic beta cell. J. Biol. Chem. 264: 15936-15942. PMid:2550428   Marcinkevage JA and Narayan KM (2011). Gestational diabetes mellitus: taking it to heart. Prim. Care Diabetes 5: 81-88. PMid:21106447   Matschinsky FM (2009). Assessing the potential of glucokinase activators in diabetes therapy. Nat. Rev. Drug. Discov. 8: 399-416. PMid:19373249   Matschinsky FM and Ellerman JE (1968). Metabolism of glucose in the islets of Langerhans. J. Biol. Chem. 243: 2730-2736. PMid:4870741   Matschinsky FM, Magnuson MA, Zelent D, Jetton TL, et al. (2006). The network of glucokinase-expressing cells in glucose homeostasis and the potential of glucokinase activators for diabetes therapy. Diabetes 55: 1-12. PMid:16380470   Metzger BE, Phelps RL, Freinkel N and Navickas IA (1980). Effects of gestational diabetes on diurnal profiles of plasma glucose, lipids, and individual amino acids. Diabetes Care 3: 402-409. PMid:7190092   Metzger BE, Lowe LP, Dyer AR, Trimble ER, et al. (2008). Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 358: 1991-2002. PMid:18463375   Meyers-Seifer CH and Vohr BR (1996). Lipid levels in former gestational diabetic mothers. Diabetes Care 19: 1351-1356. PMid:8941463   Orita M, Iwahana H, Kanazawa H, Hayashi K, et al. (1989). Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc. Natl. Acad. Sci. U. S. A. 86: 2766-2770. PMid:2565038 PMCid:286999   Osbak KK, Colclough K, Saint-Martin C, Beer NL, et al. (2009). Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum. Mutat. 30: 1512-1526. PMid:19790256   Printz RL, Magnuson MA and Granner DK (1993). Mammalian glucokinase. Annu. Rev. Nutr. 13: 463-496. PMid:8369155   Riskin-Mashiah S, Younes G, Damti A and Auslender R (2009). First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32: 1639-1643. PMid:19549728 PMCid:2732138   Rivero K, Portal VL, Vieira M and Behle I (2008). Prevalence of the impaired glucose metabolism and its association with risk factors for coronary artery disease in women with gestational diabetes. Diabetes Res. Clin. Pract. 79: 433-437. PMid:18045723   Rose CS, Ek J, Urhammer SA, Glumer C, et al. (2005). A -30G>A polymorphism of the beta-cell-specific glucokinase promoter associates with hyperglycemia in the general population of whites. Diabetes 54: 3026-3031. PMid:16186409   Rosenberg TJ, Garbers S, Lipkind H and Chiasson MA (2005). Maternal obesity and diabetes as risk factors for adverse pregnancy outcomes: differences among 4 racial/ethnic groups. Am. J. Public. Health 95: 1545-1551. PMid:16118366 PMCid:1449396   Rubio-Cabezas O, Klupa T and Malecki MT (2011). Permanent neonatal diabetes mellitus - the importance of diabetes differential diagnosis in neonates and infants. Eur. J. Clin. Invest. 41: 323-333. PMid:21054355   Ruzzo A, Andreoni F and Magnani M (1998). Structure of the human hexokinase type I gene and nucleotide sequence of the 5' flanking region. Biochem. J. 331 (Pt 2): 607-613. PMid:9531504 PMCid:1219395   Santos IC, Daga DR, Frigeri HR, Rea RR, et al. (2010a). The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians. Genet. Mol. Res. 9: 1130-1135. PMid:20568058   Santos IC, Frigeri HR, Rea RR, Almeida AC, et al. (2010b). The glucokinase gene promoter polymorphism -30G>A (rs1799884) is associated with fasting glucose in healthy pregnant women but not with gestational diabetes. Clin. Chim. Acta 411: 892-893. PMid:20227404   Schmidt MI, Matos MC, Reichelt AJ, Forti AC, et al. (2000). Prevalence of gestational diabetes mellitus - do the new WHO criteria make a difference? Brazilian Gestational Diabetes Study Group. Diabet. Med. 17: 376-380. PMid:10872537   Souza RL, Mikami LR, Maegawa RO and Chautard-Freire-Maia EA (2005). Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample. Mol. Genet. Metab. 84: 349-353. PMid:15781196   Stoffel M, Froguel P, Takeda J, Zouali H, et al. (1992). Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 89: 7698-7702. PMid:1502186 PMCid:49778   Tinto N, Zagari A, Capuano M, De Simone A, et al. (2008). Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. PLoS One 3: e1870.   Weedon MN, Frayling TM, Shields B, Knight B, et al. (2005). Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes 54: 576-581. PMid:15677518
I. C. R. Santos, Daga, D. R., Frigeri, H. R., Réa, R. R., Almeida, A. C. R., Souza, E. M., Pedrosa, F. O., Fadel-Picheth, C. M. T., and Picheth, G., The functional polymorphisms -429T>C and -374T>A of the RAGE gene promoter are not associated with gestational diabetes in Euro-Brazilians, vol. 9. pp. 1130-1135, 2010.
Bierhaus A and Nawroth PP (2009). Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52: 2251-2263. PMid:19636529   Bierhaus A, Humpert PM, Morcos M, Wendt T, et al. (2005). Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83: 876-886. PMid:16133426   Bucciarelli LG, Wendt T, Rong L, Lalla E, et al. (2002). RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol. Life Sci. 59: 1117-1128. PMid:12222959   Dos Santos KG, Canani LH, Gross JL, Tschiedel B, et al. (2005). The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol. Genet. Metab. 85: 149-156. PMid:15896660   Falcone C, Campo I, Emanuele E, Buzzi MP, et al. (2004). Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int. J. Mol. Med. 14: 1061-1064. PMid:15547674   Hudson BI, Stickland MH, Futers TS and Grant PJ (2001a). Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50: 1505-1511. PMid:11375354   Hudson BI, Stickland MH, Grant PJ and Futers TS (2001b). Characterization of allelic and nucleotide variation between the RAGE gene on chromosome 6 and a homologous pseudogene sequence to its 5' regulatory region on chromosome 3: implications for polymorphic studies in diabetes. Diabetes 50: 2646-2651. PMid:11723045   JiXiong X, BiLin X, MingGong Y and ShuQin L (2003). -429T/C and -374T/A polymorphisms of RAGE gene promoter are not associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetes Care 26: 2696-2697.   Kankova K, Stejskalova A, Hertlova M and Znojil V (2005). Haplotype analysis of the RAGE gene: identification of a haplotype marker for diabetic nephropathy in type 2 diabetes mellitus. Nephrol. Dial. Transplant. 20: 1093-1102. PMid:15790669   Kirbis J, Milutinovic A, Steblovnik K, Teran N, et al. (2004). The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes. Coll. Antropol. 28: 611-616. PMid:15666591   Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444. PMid:1681511 PMCid:328920   Langer O, Yogev Y, Xenakis EM and Brustman L (2005). Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am. J. Obstet. Gynecol. 192: 1768-1776. PMid:15970805   Lappas M, Permezel M and Rice GE (2007). Advanced glycation endproducts mediate pro-inflammatory actions in human gestational tissues via nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J. Endocrinol. 193: 269- 277. PMid:17470518   Lindholm E, Bakhtadze E, Sjogren M, Cilio CM, et al. (2006). The -374 T/A polymorphism in the gene encoding RAGE is associated with diabetic nephropathy and retinopathy in type 1 diabetic patients. Diabetologia 49: 2745-2755. PMid:16969646   NCBI (2009). Single nucleotide polymorphism (NCBI). Available at [ (search rs1800624 and rs1800625)]. Accessed December 10, 2009.   Nizard J and Ville Y (2009). The fetus of a diabetic mother: sonographic evaluation. Semin. Fetal Neonatal Med. 14: 101-105. PMid:19167940   Pertynska-Marczewska M, Glowacka E, Sobczak M, Cypryk K, et al. (2009). Glycation endproducts, soluble receptor for advanced glycation endproducts and cytokines in diabetic and non-diabetic pregnancies. Am. J. Reprod. Immunol. 61: 175-182. PMid:19143681   Picheth G, Heidemann M, Pedrosa FO, Chautard-Freire-Maia EA, et al. (2007). The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population. Clin. Chim. Acta 383: 163-164. PMid:17512509   Schmidt AM, Hori O, Cao R, Yan SD, et al. (1996). RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45 (Suppl 3): S77-S80. PMid:8674899   Wiznitzer A, Mayer A, Novack V, Sheiner E, et al. (2009). Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am. J. Obstet. Gynecol. 201: 482-488. PMid:19631920